NKCx Histopathological outcome* within 12 months after cervix cytology in 2021
131 Sörmland

  Benign LSIL HSIL AIS Cancer Other PAD missing Total
Cytologi Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel
Benign sample 35 0.6% 6 0.1% 2 0.0% . . . . 1 0.0% 6010 99.3% 6054 100.0%
ASCUS 46 14.2% 60 18.6% 29 9.0% . . 2 0.6% 4 1.2% 182 56.3% 323 100.0%
LSIL 33 10.5% 77 24.4% 46 14.6% 1 0.3% 1 0.3% 5 1.6% 152 48.3% 315 100.0%
Atypical glandular cells/AGC 1 16.7% 1 16.7% . . . . 2 33.3% . . 2 33.3% 6 100.0%
Unclear atypia 2 40.0% . . 1 20.0% . . 1 20.0% . . 1 20.0% 5 100.0%
ASC-H 5 12.5% 2 5.0% 12 30.0% . . 2 5.0% 1 2.5% 18 45.0% 40 100.0%
HSIL 5 5.3% 12 12.6% 45 47.4% 3 3.2% 4 4.2% . . 26 27.4% 95 100.0%
Suspected Adenocarcinom . . . . . . 1 100.0% . . . . . . 1 100.0%
Squamous cell cancer . . . . 1 50.0% . . 1 50.0% . . . . 2 100.0%
Totalt 127 1.9% 158 2.3% 136 2.0% 5 0.1% 13 0.2% 11 0.2% 6391 93.4% 6841 100.0%

NOTE: Histopathological outcome from T83x taken into account.
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad.

* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead.
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'.
Process Registry's Class 1 (benign), 2d (LSIL) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories.
 

Snomed codes in the
category Cancer:
M80703, M81403